cg2121 60e1d7e90b UI: Implement per-scene transition overriding
Allows the ability to override what specific transition a scene may use
when transitioning to it.

(Original proposal by cg2121, reworked by Jim)

Closes jp9000/obs-studio#1052
2017-11-30 05:10:25 -08:00
2017-10-02 07:36:02 -07:00
2017-08-01 02:27:34 -07:00
2017-08-18 21:41:31 -05:00
2015-07-11 09:10:27 -07:00
2017-04-07 22:33:48 -07:00

OBS Studio <https://obsproject.com>
===================================

What is OBS Studio?
-------------------

  OBS Studio is software designed for capturing, compositing, encoding,
  recording, and streaming video content, efficiently.

  It's distributed under the GNU General Public License v2 - see the
  accompanying COPYING file for more details.

Quick Links
-----------

 - Website: https://obsproject.com

 - Help/Guides: https://github.com/jp9000/obs-studio/wiki

 - Forums: https://obsproject.com/forum/

 - Build Instructions: https://github.com/jp9000/obs-studio/wiki/Install-Instructions

 - Bug Tracker: https://obsproject.com/mantis/

   (Note: The bug tracker is linked to forum accounts.  To use the bug
   tracker, log in to a forum account)

Contributing
------------

 - If you wish to contribute code to the project, please make sure read
   the coding and commit guidelines:
   https://github.com/jp9000/obs-studio/blob/master/CONTRIBUTING.rst

 - If you wish to contribute translations, do not submit pull requests.
   Instead, please use Crowdin.  For more information read this thread:
   https://obsproject.com/forum/threads/how-to-contribute-translations-for-obs.16327/

 - Other ways to contribute are by helping people out with support on
   our forums or in our community chat.  Please limit support to topics
   you fully understand -- bad advice is worse than no advice.  When it
   comes to something that you don't fully know or understand, please
   defer to the official help or official channels. 
Description
No description provided
Readme 369 MiB
Languages
C 53.3%
C++ 35.5%
CMake 3.5%
Swift 3%
Objective-C 2.7%
Other 1.8%